In basal-like BC, characterized by an aggressive clinical outcome and metastasis, the cleavage of syndecan-1, a membrane-bound proteoglycan, via Akt SUMOylation, promotes cells proliferation and cancer progression (Nadanaka et al., 2021). This evidence concerns the gene AKT1 and breast cancer.